Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.17 (
MMP-3
)
3,419
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Matrix metalloproteases (MMPs) comprise a family of endopeptidases that are involved in remodeling the extracellular matrix and play a critical role in learning and memory. At least 24 different MMP subtypes have been identified in the human brain, but less is known about the subtype-specific actions of MMP on neuronal plasticity. The long-term potentiation (LTP) of excitatory synaptic transmission and scaling of dendritic and somatic neuronal excitability are considered substrates of memory storage. We previously found that
MMP-3
and MMP-2/9 may be differentially involved in shaping the induction and expression of excitatory postsynaptic potential (EPSP)-to-spike (E-S) potentiation in hippocampal brain slices.
MMP-3
and MMP-2/9 proteolysis was previously shown to affect the integrity or mobility of synaptic N-methyl-D-aspartate receptors (NMDARs) in vitro. However, the functional outcome of such MMP-NMDAR interactions remains largely unknown. The present study investigated the role of these MMP subtypes in E-S plasticity and NMDAR function in mouse hippocampal acute brain slices. The temporal requirement for
MMP-3
/NMDAR activity in E-S potentiation within the
CA1
field largely overlapped, and
MMP-3
but not MMP-2/9 activity was crucial for the gain-of-function of NMDARs following LTP induction. Functional changes in E-S plasticity following
MMP-3
inhibition largely correlated with the expression of cFos protein, a marker of activity-related gene transcription. Recombinant
MMP-3
promoted a gain in NMDAR-mediated field potentials and somatodendritic Ca
2+
waves. These results suggest that long-term hippocampal E-S potentiation requires transient
MMP-3
activity that promotes NMDAR-mediated postsynaptic Ca
2+
entry that is vital for the activation of downstream signaling cascades and gene transcription.
...
PMID:Matrix Metalloprotease 3 Activity Supports Hippocampal EPSP-to-Spike Plasticity Following Patterned Neuronal Activity via the Regulation of NMDAR Function and Calcium Flux. 2735 76
Long-term potentiation (LTP) is widely perceived as a memory substrate and in the hippocampal CA3-
CA1
pathway, distinct forms of LTP depend on NMDA receptors (nmdaLTP) or L-type voltage-gated calcium channels (vdccLTP). LTP is also known to be effectively regulated by extracellular proteolysis that is mediated by various enzymes. Herein, we investigated whether in mice hippocampal slices these distinct forms of LTP are specifically regulated by different metalloproteinases (MMPs). We found that
MMP-3
inhibition or knock-out impaired late-phase LTP in the CA3-
CA1
pathway. Interestingly, late-phase LTP was also decreased by MMP-9 blockade. When both
MMP-3
and MMP-9 were inhibited, both early- and late-phase LTP was impaired. Using immunoblotting, in situ zymography, and immunofluorescence, we found that LTP induction was associated with an increase in
MMP-3
expression and activity in
CA1
stratum radiatum.
MMP-3
inhibition and knock-out prevented the induction of vdccLTP, with no effect on nmdaLTP. L-type channel-dependent LTP is known to be impaired by hyaluronic acid digestion. We found that slice treatment with hyaluronidase occluded the effect of
MMP-3
blockade on LTP, further confirming a critical role for
MMP-3
in this form of LTP. In contrast to the CA3-
CA1
pathway, LTP in the mossy fiber-CA3 projection did not depend on
MMP-3
, indicating the pathway specificity of the actions of MMPs. Overall, our study indicates that the activation of perisynaptic
MMP-3
supports L-type channel-dependent LTP in the
CA1
region, whereas nmdaLTP depends solely on MMP-9.
...
PMID:Mechanisms of NMDA Receptor- and Voltage-Gated L-Type Calcium Channel-Dependent Hippocampal LTP Critically Rely on Proteolysis That Is Mediated by Distinct Metalloproteinases. 2806 22